Freedman Financial Associates’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-50
Closed -$7K 69
2022
Q1
$7K Hold
50
﹤0.01% 384
2021
Q4
$9K Hold
50
0.01% 344
2021
Q3
$8K Hold
50
0.01% 359
2021
Q2
$9K Hold
50
0.01% 349
2021
Q1
$10K Hold
50
0.01% 351
2020
Q4
$10K Buy
+50
New +$10.3K 0.01% 349

Other funds holding CLX

Freedman Financial Associates's CLX Position: Q2 2022 in Review

Freedman Financial Associates sold out of Clorox (CLX) in Q2 2022, closing a stake of 50 shares — an estimated $7K sold.

Freedman Financial Associates first reported a position in CLX in Q4 2020 and held it in 6 quarters. The position peaked at $10K in Q1 2021. 1,081 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

  • Freedman Financial Associates reported no remaining Clorox position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 50 Clorox shares in Q2 2022, an estimated $7K.
  • Freedman Financial Associates first reported a position in Clorox in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Clorox position peaked at $10K in Q1 2021.
  • 1,081 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.